<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>PENDING</status><version>v2</version><patient-age>27</patient-age><report-id>PHHY2012AU088166</report-id><gender>male</gender><reactions><reaction>Bowel infection</reaction><reaction>Diarrhoea gone since about 2 days ago</reaction><reaction>Eosinophilia</reaction><reaction>Eosinophilis 4.3</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CLOZARIL</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Schizophrenia</indication></indications><outcomes/><country>Australia</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4149694_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20130125152633</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>PHHY2012AU088166</safetyreportid>
		<primarysourcecountry>AU</primarysourcecountry>
		<occurcountry>AU</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2013-01-25</transmissiondate>
		<reporttype>2</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>2</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2012-10-05</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2013-01-23</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHHY2012AU088166</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<linkedreport>
			<linkreportnumb>308257</linkreportnumb>
		</linkedreport>
		<primarysource>
			<reportertitle>Dr.</reportertitle>
			<reportergivename>Krishna Kanth</reportergivename>
			<reporterfamilyname>Manepalli</reporterfamilyname>
			<reporterorganization>West Adelaide CMHS</reporterorganization>
			<reporterstreet>Beaufort Clinic
96 Woodville Rd</reporterstreet>
			<reportercity>Woodville</reportercity>
			<reporterstate>SA</reporterstate>
			<reporterpostcode>5011</reporterpostcode>
			<reportercountry>AU</reportercountry>
			<qualification code="1">Physician</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>AU</reportercountry>
			<qualification code="1">Physician</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<primarysource>
			<reportertitle>Mr</reportertitle>
			<reportergivename>Barry</reportergivename>
			<reporterfamilyname>Burr</reporterfamilyname>
			<reporterorganization>West Adelaide CMHS</reporterorganization>
			<reporterstreet>Beaufort Clinic, 96 Woodville Rd</reporterstreet>
			<reportercity>Woodville</reportercity>
			<reporterstate>SA</reporterstate>
			<reporterpostcode>5011</reporterpostcode>
			<reportercountry>AU</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
			<observestudytype>3</observestudytype>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>JM</patientinitial>
			<patientinvestigationnumb>JM20428</patientinvestigationnumb>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19850528</patientbirthdate>
			<patientweight>69.8</patientweight>
			<patientheight>174</patientheight>
			<patientsex code="1">Male</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Schizophrenia, paranoid type</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Drug abuse</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Tobacco abuse</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Psychotic disorder</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Alcohol abuse</patientepisodename>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Bowel infection</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Gastrointestinal infection</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Gastrointestinal infection</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120927</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20121003</reactionenddate>
				<reactionduration>7</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>21</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Diarrhoea gone since about 2 days ago</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Diarrhoea</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Diarrhoea</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120920</reactionstartdate>
				<reactionenddateformat>102</reactionenddateformat>
				<reactionenddate>20120929</reactionenddate>
				<reactionduration>10</reactionduration>
				<reactiondurationunit>804</reactiondurationunit>
				<reactionfirsttime>14</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="1">recovered/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Eosinophilia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Eosinophilia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Eosinophilia</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20120919</reactionstartdate>
				<reactionfirsttime>13</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Eosinophilis 4.3</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Eosinophil count increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Eosinophil count increased</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20121003</reactionstartdate>
				<reactionfirsttime>27</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="2">recovering/resolved</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>C-reactive protein</testname>
				<testresult>7.8</testresult>
				<testunit>mg/l</testunit>
				<lowtestrange>6.30</lowtestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>C-reactive protein</testname>
				<testresult>7.8</testresult>
				<testunit>mg/l</testunit>
				<lowtestrange>6.30</lowtestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20120924</testdate>
				<testname>Eosinophil count</testname>
				<testresult>0.8</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121003</testdate>
				<testname>Eosinophil count</testname>
				<testresult>4.3</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121005</testdate>
				<testname>Eosinophil count</testname>
				<testresult>3.0</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121009</testdate>
				<testname>Eosinophil count</testname>
				<testresult>0.9</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<test>
				<testdateformat>102</testdateformat>
				<testdate>20121015</testdate>
				<testname>Eosinophil count</testname>
				<testresult>1.2</testresult>
				<testunit>10^9/L</testunit>
				<hightestrange>&lt;0.6</hightestrange>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CLOZARIL</medicinalproduct>
				<obtaindrugcountry>AU</obtaindrugcountry>
				<drugauthorizationnumb>19-758</drugauthorizationnumb>
				<drugauthorizationcountry>AU</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>300</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugdosagetext>300 mg</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Schizophrenia</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2012-09-07</drugstartdate>
				<drugstartperiod>21</drugstartperiod>
				<drugstartperiodunit>804</drugstartperiodunit>
				<drugenddateformat>102</drugenddateformat>
				<drugenddate>2012-10-05</drugenddate>
				<drugtreatmentduration>29</drugtreatmentduration>
				<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="1">Yes</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CLOZAPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Diarrhoea</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophil count increased</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophil count increased</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophilia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Eosinophilia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal infection</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Gastrointestinal infection</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<summary>
				<narrativeincludeclinical>Case number PHHY2012AU088166, is an <Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">initial </Semaphore>PMS report received from a <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.58" ID="C19254">physician </Semaphore>via the <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>Patient Monitoring Service (CPMS - Patient Registry) on 05 Oct 2012 with follow up report received from healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>(<Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>coordinator, <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse</Semaphore>) on 10 Oct 2012 with a follow up report received from the <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>on 29 Oct 2012 with a follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.58" ID="C19254">physician </Semaphore>on 01 Nov 2012 with follow up report received from <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.58" ID="C19254">physician </Semaphore>on 23 Jan 2013. This report refers to 27-year old male patient (Patient ID: JM20428). The medical history of the patient included <Semaphore x="3241091" class="MedDRA LLT" value="Schizophrenia, paranoid type" score="1.00" ID="10039639">paranoid <Semaphore x="2499616" class="Disease or Finding" value="Schizophrenia" score="1.00" ID="C3362">schizophrenia</Semaphore></Semaphore>, <Semaphore x="1864068" class="Procedure" value="Dronabinol Measurement" score="1.00" ID="C75351">tetrahydrocannabinol </Semaphore>(THC) <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore><Semaphore x="3280719" class="MedDRA LLT" value="Tobacco abuse" score="1.00" ID="10043903">abuse</Semaphore>
    <Semaphore x="3280719" class="MedDRA LLT" value="Tobacco abuse" score="1.00" ID="10043903">, <Semaphore x="926931" class="Medicine" value="Nicotine" score="0.49" ID="282241">nicotine </Semaphore><Semaphore x="2726271" class="MedDRA LLT" value="Alcohol abuse" score="1.00" ID="10001584">abuse </Semaphore></Semaphore>
    <Semaphore x="2726271" class="MedDRA LLT" value="Alcohol abuse" score="1.00" ID="10001584">and alcohol abuse</Semaphore>. The patient received <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>(<Semaphore x="385490" class="Medicine" value="Clozapine" score="0.49" ID="252210">clozapine</Semaphore>) for the <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>of <Semaphore x="2499616" class="Disease or Finding" value="Schizophrenia" score="1.00" ID="C3362">schizophrenia</Semaphore>, at a dose of 300 mg from 07 Sep 2012. On 19 Sep 2012 the patient was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia</Semaphore>. On 20 Sep 2012 the patient experienced <Semaphore x="1847734" class="Disease or Finding" value="Diarrhea" score="1.00" ID="C2987">diarrhoea</Semaphore>. On 24 Sep 2012 laboratory data of the patient revealed that <Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophils </Semaphore>was 0.8x10^9/L. On 27 Sep 2012 the patient was <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore>with <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection</Semaphore>. The <Semaphore x="2424395" class="Procedure" value="Problem Tasting Food at its Worst" score="1.00" ID="C105545">issue </Semaphore>of raised <Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophils </Semaphore>was discussed with <Semaphore x="2013324" class="Occupation" value="Hematologist" score="1.00" ID="C17831">haematologist </Semaphore>and might be due to a <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>which started at approximately the same time as <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril</Semaphore>. The patient received <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>medication of antibiotics and antidiarrheal. On 03 Oct 2012, laboratory data of the patient revealed that <Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophils </Semaphore>count was 4.3x10^9/L. (normal range: &lt;0.6) It was reported that patient had not been on <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>for long period. The patient was on <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>for 03 weeks and responded very well. On 05 Oct 2012, patient's <Semaphore x="1653868" class="Procedure" value="C-Reactive Protein Measurement" score="1.00" ID="C64548">CRP </Semaphore>(<Semaphore x="1653868" class="Procedure" value="C-Reactive Protein Measurement" score="1.00" ID="C64548">C reactive protein</Semaphore>) was reported as 7.8 mg/L. <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Treatment </Semaphore>with <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>was discontinued on 05 Oct 2012 (previously reported as 06 Oct 2012). It was also reported the patient would recommence the <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>after a three week. On 09 Oct 2012 laboratory data of the patient revealed that <Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophils </Semaphore>was 0.9x10^9/L. On 15 Oct 2012 laboratory data of the patient revealed that <Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophils </Semaphore>was 1.2x10^9/L. The seriousness of the events <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection</Semaphore>, <Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia</Semaphore>, eosinophilis 4.3 and <Semaphore x="1847734" class="Disease or Finding" value="Diarrhea" score="1.00" ID="C2987">diarrhea </Semaphore>was assessed as medically significant and seriousness criteria for other event was not reported. The <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event <Semaphore x="1847734" class="Disease or Finding" value="Diarrhea" score="1.00" ID="C2987">diarrhoea </Semaphore>was completely recovered on 29 Sep 2012, <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>was completely recovered on 03 Oct 2012 and for other events was reported as condition improving. The causality of the event <Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia </Semaphore>was reported as suspected and causality <Semaphore x="2397639" class="Procedure" value="Physical Examination" score="1.00" ID="C20989">assessment </Semaphore>for <Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>and <Semaphore x="1847734" class="Disease or Finding" value="Diarrhea" score="1.00" ID="C2987">diarrhea </Semaphore>was reported as not suspected with <Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>and for other event was not reported.Follow up report received from healthcare <Semaphore x="2425040" class="Occupation" value="Professional Occupation" score="1.00" ID="C75558">professional </Semaphore>(<Semaphore x="385527" class="Medicine" value="Clozaril" score="1.00" ID="247865">Clozaril </Semaphore>coordinator) on 10 Oct 2012: Updated reporter's information, suspect <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>information and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event (<Semaphore x="2933848" class="MedDRA LLT" value="Eosinophil count increased" score="1.00" ID="10014945"><Semaphore x="1889898" class="Procedure" value="Eosinophil Count" score="1.00" ID="C64550">eosinophil count </Semaphore>increased</Semaphore>). Added events (<Semaphore x="1965722" class="Disease or Finding" value="Gastrointestinal Infection" score="1.00" ID="C35503">gastrointestinal infection </Semaphore>and <Semaphore x="2835678" class="MedDRA LLT" value="C-reactive protein increased" score="1.00" ID="10006825"><Semaphore x="1653868" class="Procedure" value="C-Reactive Protein Measurement" score="1.00" ID="C64548">C reactive protein </Semaphore>increased</Semaphore>).Follow up report received from the <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>on 29 Oct 2012: Updated information patient's demography (date of birth), event (<Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia</Semaphore>) and <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event (<Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia</Semaphore>).Follow up report received from the <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.58" ID="C19254">physician </Semaphore>on 01 Nov 2012: Updated reporter information, <Semaphore x="2091429" class="Disease or Finding" value="Laboratory Test Result" score="1.00" ID="C36292">lab </Semaphore>data, medical history, and concomitant medication, suspect product (dosage and stop date). Seriousness, <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and causality of event eosinophilis 4.3 and <Semaphore x="1847734" class="Disease or Finding" value="Diarrhea" score="1.00" ID="C2987">diarrhea </Semaphore>were updated.Follow up report received from <Semaphore x="2209876" class="Occupation" value="Medical Occupation" score="0.58" ID="C19254">physician </Semaphore>on 23 Jan 2013: The patient demography, concurrent condition, laboratory data of (24 Sep 2012, 09 Oct 2012 and 15 Oct 2012), onset date, seriousness, <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>and causality of the events (<Semaphore x="2068954" class="AnatomicStructure" value="Intestine" score="1.00" ID="C12736">bowel </Semaphore><Semaphore x="3033151" class="MedDRA LLT" value="Infection" score="1.00" ID="10021789">infection </Semaphore>and <Semaphore x="1889985" class="Disease or Finding" value="Eosinophilia" score="1.00" ID="C3015">eosinophilia</Semaphore>) updated.</narrativeincludeclinical>
				<sendercomment>Based on  Review of available reported data does not allow for a proper causality assessment. Reported event gastrointestinal infection is unassessable.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>